zoledronic acid injection, solution, concentrate
breckenridge pharmaceutical, inc - zoledronic acid (unii: 6xc1pad3kf) (zoledronic acid anhydrous - unii:70hz18ph24) - zoledronic acid anhydrous 4 mg in 5 ml - zoledronic acid injection is indicated for the treatment of hypercalcemia of malignancy defined as an albumin-corrected calcium (cca) of greater than or equal to 12 mg/dl [3.0 mmol/l] using the formula: cca in mg/dl=ca in mg/dl + 0.8 (4.0 g/dl - patient albumin [g/dl]). zoledronic acid injection is indicated for the treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors, in conjunction with standard antineoplastic therapy. prostate cancer should have progressed after treatment with at least one hormonal therapy. limitations of use the safety and efficacy of zoledronic acid injection in the treatment of hypercalcemia associated with hyperparathyroidism or with other non-tumor-related conditions have not been established. hypersensitivity to zoledronic acid or any components of zoledronic acid injection hypersensitivity reactions including rare cases of urticaria and angioedema, and very rare cases of anaphylactic reaction/shock have been reported [see adverse
magnesium trisilicate compound tablets
a a h pharmaceuticals ltd - magnesium trisilicate; aluminium hydroxide dried - oral tablet - 250mg ; 120mg
magnesium trisilicate compound tablets
the boots company plc - magnesium trisilicate; aluminium hydroxide dried - oral tablet - 250mg ; 120mg
magnesium trisilicate compound tablets
alliance healthcare (distribution) ltd - magnesium trisilicate; aluminium hydroxide dried - oral tablet - 250mg ; 120mg
magnesium trisilicate compound tablets
sussex pharmaceutical ltd - magnesium trisilicate; aluminium hydroxide dried - oral tablet - 250mg ; 120mg
magnesium trisilicate compound tablets
phoenix healthcare distribution ltd - magnesium trisilicate; aluminium hydroxide dried - oral tablet - 250mg ; 120mg
magnesium trisilicate compound tablets
sigma pharmaceuticals plc - magnesium trisilicate; aluminium hydroxide dried - oral tablet - 250mg ; 120mg
magnesium trisilicate compound tablets
cubic pharmaceuticals ltd - magnesium trisilicate; aluminium hydroxide dried - oral tablet - 250mg ; 120mg
alendronic acid/cholecalciferol accord 70mg/2800iu tablets
accord healthcare ireland ltd. - alendronic acid; vitamin d3 - tablet - 70 mg/2800 international unit(s) - alendronic acid and colecalciferol
alendronic acid/cholecalciferol accord 70 mg/5600 iu tablets
accord healthcare ireland ltd. - vitamin d3; alendronic acid - tablet - 70 mg/5600 international unit(s) - alendronic acid and colecalciferol